ClinicalTrials.Veeva

Menu

Fecal Microbiota Transplantation for Radiation Enteritis

N

Nanjing Medical University

Status

Enrolling

Conditions

Radiation Enteritis

Treatments

Procedure: Fecal Microbiota Transplantation (FMT)

Study type

Interventional

Funder types

Other

Identifiers

NCT03516461
FMT-RE-201702

Details and patient eligibility

About

Radiation enteritis is one of the most feared complications after abdominal or pelvic radiation therapy.The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body metabolism. Evidence from animal studies demonstrated the link between intestinal bacteria and radiation enteritis. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) for radiation enteritis.

Full description

The present clinical trial aims to re-establish a gut functionality state of intestinal microbiota through fecal microbiota transplantation (FMT) for radiation enteritis (RE). FMT is the whole profile of fecal microbiota transplantation. At enrollment, "Shared Decision Making" intervention was applied to support patient involvement in making health decisions. Patients have opportunity to choose fecal microbiota transplantation (FMT). Patients will receive follow-up for at least 12 weeks. Blood test, endoscopy and questionnaire will be used to access participants at study start and at study completion. Fecal microbiota compositions, blood and urinary metabolic profiles of patients will be analyzed to assess associated microbial changes.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. age ≥18 years old;
  2. Radiation enteritis diagnosed by colonoscopy after finishing radiotherapy.

Exclusion criteria

  1. Patients who were pregnant or nursing;
  2. Patients who were unable or unwilling to undergo a gastroscopy;
  3. Patients who had gastrointestinal infection;
  4. Patients with cardiopulmonary failure.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Fecal Microbiota Transplantation (FMT)
Experimental group
Description:
Patients receive a course of FMT during hospitalization
Treatment:
Procedure: Fecal Microbiota Transplantation (FMT)
Basic treatment
No Intervention group
Description:
Patient receives basic therapy for RE during hospitalization

Trial contacts and locations

1

Loading...

Central trial contact

Faming Zhang, MD; PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems